 Ovarian cancer was mostly diagnosed at late stage IIIIV with high rate of recurrence after first line of therapy by optimal cytoreductive sugery and 6-8cycle of TP chemotherapy. We developed an adjuvant chemotherapy of three steps ACTS. It is adding CTXVP-16second step6cycle and CTXCBPthird steps to firstline chemotherapy first step. The aim of this study is to verify the effectivity and safety of ACTS. 